These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

110 related articles for article (PubMed ID: 8126405)

  • 21. Modeling the impact of HIV chemoprophylaxis strategies among men who have sex with men in the United States: HIV infections prevented and cost-effectiveness.
    Desai K; Sansom SL; Ackers ML; Stewart SR; Hall HI; Hu DJ; Sanders R; Scotton CR; Soorapanth S; Boily MC; Garnett GP; McElroy PD
    AIDS; 2008 Sep; 22(14):1829-39. PubMed ID: 18753932
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Clinical decision analysis of HIV screening.
    Yawn BP
    Fam Med; 1992 Jul; 24(5):355-61. PubMed ID: 1326454
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Economic evaluation of HIV screening in pregnant women attending antenatal clinics in India.
    Kumar M; Birch S; Maturana A; Gafni A
    Health Policy; 2006 Jul; 77(2):233-43. PubMed ID: 16126300
    [TBL] [Abstract][Full Text] [Related]  

  • 24. The cost-effectiveness of HIV testing of physicians and dentists in the United States.
    Phillips KA; Lowe RA; Kahn JG; Lurie P; Avins AL; Ciccarone D
    JAMA; 1994 Mar; 271(11):851-8. PubMed ID: 8114240
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Efficiency and cost-effectiveness of dyslipidemia screening methods among workers in Bangkok.
    Sanguantrakul U; Jiamjarasrangsi W; Vimolket T
    Southeast Asian J Trop Med Public Health; 2010 Jan; 41(1):215-23. PubMed ID: 20578501
    [TBL] [Abstract][Full Text] [Related]  

  • 26. HIV screening of surgeons and dentists: a cost-effectiveness analysis.
    Sell RL; Jovell AJ; Siegel JE
    Infect Control Hosp Epidemiol; 1994 Oct; 15(10):635-45. PubMed ID: 7844334
    [TBL] [Abstract][Full Text] [Related]  

  • 27. The cost-effectiveness of voluntary counseling and testing of hospital inpatients for HIV infection.
    Lurie P; Avins AL; Phillips KA; Kahn JG; Lowe RA; Ciccarone D
    JAMA; 1994 Dec; 272(23):1832-8. PubMed ID: 7990217
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Cost-effectiveness of screening for HIV.
    Taiwo BO
    N Engl J Med; 2005 May; 352(20):2137-9; author reply 2137-9. PubMed ID: 15901873
    [No Abstract]   [Full Text] [Related]  

  • 29. Benefits of HIV screening of blood transfusions in Zambia.
    Foster S; Buvé A
    Lancet; 1995 Jul; 346(8969):225-7. PubMed ID: 7616804
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Cost-effectiveness of mandatory compared with voluntary screening for human immunodeficiency virus in pregnancy.
    Myers ER; Thompson JW; Simpson K
    Obstet Gynecol; 1998 Feb; 91(2):174-81. PubMed ID: 9469271
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Screening surgeons for HIV infection: assessment of a potential public health program.
    Schulman KA; McDonald RC; Lynn LA; Frank I; Christakis NA; Schwartz JS
    Infect Control Hosp Epidemiol; 1994 Mar; 15(3):147-55. PubMed ID: 8207171
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Technology ... how cost effective would it be to test health care workers for HIV?
    Hosp Health Netw; 1994 May; 68(9):19. PubMed ID: 8167751
    [No Abstract]   [Full Text] [Related]  

  • 33. Potential cost of screening surgeons for HIV.
    Roizen MF; Foss J; Mantha S
    JAMA; 1994 Aug; 272(6):434-5. PubMed ID: 8040976
    [No Abstract]   [Full Text] [Related]  

  • 34. HIV screening for healthcare providers: can we provide sense and sensibility without pride or prejudice?
    Henderson DK
    Infect Control Hosp Epidemiol; 1994 Oct; 15(10):631-4. PubMed ID: 7844333
    [No Abstract]   [Full Text] [Related]  

  • 35. Screening surgeons for HIV infection. A cost-effectiveness analysis.
    Owens DK; Harris RA; Scott PM; Nease RF
    Ann Intern Med; 1995 May; 122(9):641-52. PubMed ID: 7702225
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Emergency department HIV screening with rapid tests: a cost comparison of alternative models.
    Hutchinson AB; Farnham PG; Lyss SB; White DA; Sansom SL; Branson BM
    AIDS Educ Prev; 2011 Jun; 23(3 Suppl):58-69. PubMed ID: 21689037
    [TBL] [Abstract][Full Text] [Related]  

  • 37. The impact of expected HIV transmission rates on the effectiveness and cost of ruling out HIV infection in infants.
    Mrus JM; Yi MS; Eckman MH; Tsevat J
    Med Decis Making; 2002; 22(5 Suppl):S38-44. PubMed ID: 12369230
    [TBL] [Abstract][Full Text] [Related]  

  • 38. A cost-benefit analysis of voluntary routine HIV-antibody testing for hospital patients.
    La Croix SJ; Russo G
    Soc Sci Med; 1996 May; 42(9):1259-72. PubMed ID: 8733196
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Cost-effectiveness of pooled nucleic acid amplification testing for acute HIV infection after third-generation HIV antibody screening and rapid testing in the United States: a comparison of three public health settings.
    Hutchinson AB; Patel P; Sansom SL; Farnham PG; Sullivan TJ; Bennett B; Kerndt PR; Bolan RK; Heffelfinger JD; Prabhu VS; Branson BM
    PLoS Med; 2010 Sep; 7(9):e1000342. PubMed ID: 20927354
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Transmission of the human immunodeficiency virus in the health care setting--time for action.
    Brennan TA
    N Engl J Med; 1991 May; 324(21):1504-9. PubMed ID: 2023611
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.